1016 Prognostic and predictive significance of BRAF mutation in patients with metastatic colorectal cancer treated with 5-fluorouracil-based 1st line chemotherapy

Z.Saridaki; M.Tzardi; D.Papadatos-Patsos; E.Kampouraki; E.Zois; E.Stathopoulos; V.Georgoulias; D.Mavroudis; J.Souglakos

首页> 外文期刊>European Journal of Cancer Supplements >1016 Prognostic and predictive significance of BRAF mutation in patients with metastatic colorectal cancer treated with 5-fluorouracil-based 1st line chemotherapy

【24h】

1016 Prognostic and predictive significance of BRAF mutation in patients with metastatic colorectal cancer treated with 5-fluorouracil-based 1st line chemotherapy

机译：1016 BRAF突变在以5-氟尿嘧啶为基础的一线化疗治疗的转移性结直肠癌患者中的预后和预测意义

获取原文

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《European Journal of Cancer Supplements》 |2009年第2期|共2页
作者
Z.Saridaki; M.Tzardi; D.Papadatos-Patsos; E.Kampouraki; E.Zois; E.Stathopoulos; V.Georgoulias; D.Mavroudis; J.Souglakos;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种
中图分类肿瘤学;
关键词

相似文献

外文文献
中文文献
专利

1. Predictive and prognostic roles of BRAF mutation in patients with metastatic colorectal cancer treated with anti-epidermal growth factor receptor monoclonal antibodies: A meta-analysis [J] . XuQ., XuA.T., ZhuM.M., Journal of digestive diseases . 2013,第8期

机译：抗表皮生长因子受体单克隆抗体治疗BRAF突变在转移性结直肠癌患者中的预测和预后作用：一项荟萃分析
2. KRAS and BRAF Mutations as Prognostic and Predictive Biomarkers for Standard Chemotherapy Response in Metastatic Colorectal Cancer: A Single Institutional Study [J] . Progress in Artificial Intelligence . 2020,第1期

机译：KRAS和BRAF突变作为预测和预测生物标志物，用于转移结直肠癌中的标准化疗反应：单一的制度研究
3. Prognostic significance of thymidylate synthase, dihydropyrimidine dehydrogenase and thymidine phosphorylase protein expression in colorectal cancer patients treated with or without 5-fluorouracil-based chemotherapy. [J] . Soong R, Shah N, Salto-Tellez M, Annals of oncology: official journal of the European Society for Medical Oncology . 2008,第5期

机译：胸苷酸合酶，二氢嘧啶脱氢酶和胸苷磷酸化酶蛋白表达在以或不以5-氟尿嘧啶为基础的化学疗法治疗的大肠癌患者中的预后意义。
4. Isolation of Circulating Tumor Cells from Patients with Metastatic Colorectal Cancer Using Label-Free Microfluidic Technology for Enumeration and Detection of KRAS, BRAF, PIK3CA Mutation [C] . Haiyan Emily Liu, Evelyn Kidess-Sigal, Melanie Triboulet, International Molecular Medicine Tri-Conference. . 2016

机译：使用无标记微流体技术分离转移性结肠直肠癌患者的循环肿瘤细胞进行募准和检测KRA，BRAF，PIK3CA突变
5. Evaluation of the accuracy of quantitative models in predicting Lynch syndrome (hereditary nonpolyposis colorectal cancer with defective DNA mismatch repair) mutations in a population-based sample of early-onset colorectal cancer patients [D] . Carpiniello, Lauren 2007

机译：在以人群为基础的早发性大肠癌患者样本中预测定量模型预测Lynch综合征（遗传性非息肉病性大肠直肠癌，DNA失配修复缺陷）的准确性
6. Prognostic significance of thymidylate synthase dihydropyrimidine dehydrogenase and thymidine phosphorylase protein expression in colorectal cancer patients treated with or without 5-fluorouracil-based chemotherapy [O] . R. Soong, N. Shah, M. Salto-Tellez, -1

机译：胸苷酸合酶二氢嘧啶脱氢酶和胸苷磷酸化酶蛋白表达在接受或不接受基于5-氟尿嘧啶的大肠癌治疗中的预后意义
7. The impact of the Glasgow Prognostic Score on survival in second-line chemotherapy for metastatic colorectal cancer patients with BRAF V600E mutation [O] . Seiichiro Mitani, Hiroya Taniguchi, Keiji Sugiyama, 2019

机译：Glasgow预后评分对BRAF v600E突变转移结直肠癌患者的二线化疗存活

1016 Prognostic and predictive significance of BRAF mutation in patients with metastatic colorectal cancer treated with 5-fluorouracil-based 1st line chemotherapy

著录项

相似文献

相关主题

期刊订阅